Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 1.43 | -3.92 |
| PEG Ratio (TTM) | -0.10 | -1.74 |
| P/S Ratio (TTM) | N/A | 1.25 |
| P/B Ratio (TTM) | 0.09 | 3.25 |
| P/FCF Ratio (TTM) | N/A | 17.33 |
| Price to 5YR AVG Earnings Ratio | N/A | 5.90 |
| Price to 5YR AVG FCF Ratio | N/A | 7.67 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.61% | 0.59% |
| ROE (TTM) | 5.79% | 8.66% |
| Net Profit Margin (TTM) | N/A | 5.70% |
| ROIC 5YR AVG | N/A | 4.78% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 46.85% | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | 54.10% | N/A | N/A |
| Cash Flow | 429.35% | N/A | N/A |
Health (12%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.00 | 0.51 |
| Quick Ratio (TTM) | 0.00 | -0.90 |
| D/E Ratio (TTM) | N/A | 3.40 |
| Interest Coverage (TTM) | 0.50 | 3.19 |
| Piotroski F-Score | 2 | 5 |
| Altman Z-Score | 0.04 | 1.46 |
| LTL to 5YR AVG FCF | N/A | 25.63 |
| Shares Outstanding Growth 5YR AVG | N/A | -7.49% |